Paterson D L, Mulazimoglu L, Casellas J M, Ko W C, Goossens H, Von Gottberg A, Mohapatra S, Trenholme G M, Klugman K P, McCormack J G, Yu V L
Infectious Disease Section, Veterans Affairs Medical Center, Pittsburgh, PA 15240, USA.
Clin Infect Dis. 2000 Mar;30(3):473-8. doi: 10.1086/313719.
A prospective study of Klebsiella pneumoniae bacteremia was performed in 12 hospitals in 7 countries. Of 452 episodes of bacteremia, 25 (5.5%) were caused by K. pneumoniae that was resistant in vitro to ciprofloxacin. Extended-spectrum beta-lactamase (ESBL) production was detected in 15 (60%) of 25 ciprofloxacin-resistant isolates, compared with 68 (16%) of 427 ciprofloxacin-susceptible strains (P=.0001). Multivariate analysis revealed that risk factors for ciprofloxacin resistance in K. pneumoniae included prior receipt of a quinolone (P=.0065) and an ESBL-producing strain (P=.012). In all, 18% of ESBL-producing isolates were also ciprofloxacin-resistant. Pulsed-field gel electrophoresis showed that 11 of the 15 ciprofloxacin-resistant ESBL-producing strains belonged to just 4 genotypes, suggesting that patient-to-patient transmission of such strains occurred. The close relationship between ESBL production and ciprofloxacin resistance is particularly worrisome because the first reported instance of plasmid-mediated ciprofloxacin resistance has been in an isolate of K. pneumoniae also possessing an ESBL.
在7个国家的12家医院开展了一项关于肺炎克雷伯菌菌血症的前瞻性研究。在452例菌血症病例中,有25例(5.5%)由体外对环丙沙星耐药的肺炎克雷伯菌引起。在25株环丙沙星耐药菌株中,有15株(60%)检测到产超广谱β-内酰胺酶(ESBL),而在427株环丙沙星敏感菌株中有68株(16%)产ESBL(P = 0.0001)。多变量分析显示,肺炎克雷伯菌对环丙沙星耐药的危险因素包括先前接受过喹诺酮治疗(P = 0.0065)和产ESBL菌株(P = 0.012)。总体而言,产ESBL的分离株中有18%也对环丙沙星耐药。脉冲场凝胶电泳显示,15株对环丙沙星耐药且产ESBL的菌株中有11株仅属于4种基因型,这表明此类菌株在患者之间发生了传播。产ESBL与环丙沙星耐药之间的密切关系尤其令人担忧,因为首次报道的质粒介导的环丙沙星耐药实例发生在一株也携带ESBL的肺炎克雷伯菌分离株中。